Clinical Trial Update: Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing endovascular treatment with versus without intravenous rhTNK-tPA in acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Stroke, Acute, Stroke, Ischemic | Phase 2, Phase 3 | Status: COMPLETED